Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

FGFR4 Gene Mutation: early-phase trial registry

1 of 1 indexed FGFR4 Gene Mutation trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

FGFR4 Gene Mutation: 1 US clinical trial tracked, 1 recruiting.

FGFR4 Gene Mutation is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tyra Biosciences, running 1 of these trials.

Enrollment posture brief

Registry condition fgfr4-gene-mutation

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

FGFR4 Gene Mutation (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near FGFR4 Gene Mutation

FGFR4 Gene Mutation lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for FGFR4 Gene Mutation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. FGFR4 Gene Mutation is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Tyra Biosciences 1 trials

Named interventions

Most-linked intervention names on FGFR4 Gene Mutation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

TYRA-430 Drug
1 trials

US sites by state

Facility locations filed on FGFR4 Gene Mutation trials. A trial with sites in several states counts in each.

Tennessee 1 trials
New York 1 trials
Michigan 1 trials
Maryland 1 trials
Massachusetts 1 trials
Kansas 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this FGFR4 Gene Mutation page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 FGFR4 Gene Mutation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tyra Biosciences sponsors the most FGFR4 Gene Mutation trials on record, review their full trial history before evaluating a specific study. See Tyra Biosciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This FGFR4 Gene Mutation condition card totals 1 registered trials; most-linked intervention TYRA-430; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.